Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocomer Technology is a Shanghai-based medical technology company specializing in the development and manufacturing of in vitro diagnostic (IVD) solutions. The company focuses on high-throughput chemiluminescence immunoassay (CLIA) systems and a broad portfolio of reagents covering infectious diseases, cardiac markers, and inflammatory indicators. Biocomer aims to provide cost-effective, high-performance diagnostic tools for hospitals and clinical laboratories, leveraging its proprietary automated platforms. Their products are designed to improve the efficiency and accuracy of clinical testing in the Chinese and international markets. The company has successfully commercialized several generations of automated analyzers and dozens of diagnostic assays. Backed by prominent venture capital firms, Biocomer continues to expand its R&D capabilities to address unmet needs in rapid clinical testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocomer Technology.